Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for.

Wall Street analysts expect 10x Genomics (TXG) to post quarterly loss of $0.32 per share in its upcoming report, which indicates a year-over-year increase of 22%. Revenues are expected to be $158.14 ...

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M ...

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...

Technological advances have reduced genome sequencing costs to $600, boosting growth in the genomics sector. The genetic testing market is forecast to hit $91.3 billion by 2034, enhancing disease ...

International collaboration in genomic research is gaining momentum in African countries and is often supported by external ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

Indian healthcare industry keen on paving way for accessible & scalable precision medicine: Nandita Vijayasimha, Bengaluru Wednesday, February 12, 2025, 08:00 Hrs [IST] Indian hea ...